Why psychological safety could be the culture signal investors are missing

Tern plc

Psychological safety is rarely listed in an investor deck, yet it may be one of the most telling indicators of a company’s internal resilience. When employees do not feel safe to speak up, performance risk compounds. Mistakes go unreported, dissent is withheld and innovation stalls. No amount of wellbeing perks can offset a culture where silence is the safer choice.

In operational terms, psychological safety refers to whether people feel able to express ideas, raise concerns or admit to errors without fear of embarrassment or penalty. It is a force that influences how teams learn, how managers lead and how quickly organisations adapt to change. In sectors where human input is critical, such as healthcare, pharmaceuticals or regulated industries, the stakes are especially high. Employee voice is a potential early warning system for operational fragility.

Many firms rely on scheduled surveys to monitor wellbeing, but these often miss what matters most. Disengagement does not wait for a questionnaire. It appears first in tone, language and unspoken withdrawal, all of which go undetected when companies listen only through formal channels.

The companies addressing this are using more advanced analysis of internal feedback, applying natural language processing to employee comments, suggestion boxes, and internal channels to identify where trust may be breaking down. Signals such as hesitancy to report errors, inconsistent feedback, or negative sentiment around leadership can be flagged earlier. Dashboards then equip HR teams to pinpoint the cultural blind spots before they harden into risk.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

AI control of machines creates a new market for device trust

AI is beginning to control physical machines, increasing demand for technology that can verify device identity before those machines are allowed to act.

Peptide drug development expands beyond GLP-1

GLP-1 success is widening interest in peptide drug development, with the next phase focused on proving clinical value across new therapeutic areas.

Tern Plc announces 90% take-up of Open Offer

Tern Plc has received valid acceptances for 50.9 million Open Offer Shares, representing approximately 90% of the shares available. The fully underwritten offer will raise approximately £509,368 before expenses, with admission of the new shares expected on 24 September 2026.

Talking Medicines moves to capture pharma demand for better patient intelligence

Tighter US pharma advertising rules could increase demand for patient intelligence, supporting the relevance of Talking Medicines’ DrugVoice platform.

Tern portfolio company Talking Medicines launches ‘Intent to Prescribe’ DrugVoice application

Talking Medicines has launched a new DrugVoice application combining its Message Resonance Score™ with near-real-time point-of-care data to help pharmaceutical companies assess links between HCP message alignment and prescribing intent.

Device Authority targets secure digital infrastructure for smart ports

Device Authority's Smart, Green Port Blueprint shows how secure device management can support the wider rollout of connected infrastructure across modern ports.

Search